1. Williams, D. L. H., & Davis, H. T. (2016). The role of pharma grade compounds in drug development. Journal of Medicinal Chemistry, 59(5), 1671-1692.
2. Smith, K., & Gupta, R. K. (2015). Pharma Grade compounds for improved therapies: current trends and future directions. Journal of Controlled Release, 202, 1-12.
3. Wilson, R. M., Danishefsky, S. J., & Onaivi, E. S. (2017). Pharma grade compounds and their potential in cancer treatment. Cancer Research, 77(9), 2147-2152.
4. Yang, M. C., Ma, G., & Liu, C. Y. (2018). Pharma grade compounds for gene therapy: principles, challenges, and perspectives. Advanced Drug Delivery Reviews, 132, 1-27.
5. Reed, D. D., & Gierasch, L. M. (2014). Pharma grade compounds as tools in protein research. Molecular Cell, 55(2), 139-153.
6. Green, C. J., & Lemaire, M. (2017). Pharma grade compounds in neuroscience research: from basic science to therapeutic applications. Current Opinion in Neurobiology, 44, 139-144.
7. Li, Y., & Xiong, Y. (2017). Pharma grade compounds for improved drug delivery: current progress and future directions. Journal of Controlled Release, 260, 73-80.
8. Baldrick, P. (2015). Pharmaceutical-grade compounds for immunotherapy and vaccine production: a review. Critical Reviews in Biotechnology, 35(1), 113-120.
9. Wood, M. J. A., & Gait, M. J. (2017). Pharma grade oligonucleotides: recent advances and future prospects. Trends in Biotechnology, 35(11), 956-969.
10. Kavallaris, M., & Haber, M. (2018). Pharma grade compounds for cancer therapy: progress and challenges. Nature Reviews Cancer, 18(2), 84-88.